Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia
In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events were a turning point for individuals with hemophilia A and...
Online Exclusives
U.K. Labour Party Plans to Regulate Pharmaceutical Market, Lower Drug Prices
The U.K. Labour Party has pledged to reform the country’s pharmaceutical market by establishing a publicly owned generic drug manufacturer and expanding the government’s...
Federal Watchdog Report Shows NIH Must Better Protect U.S. Research From...
New reports issued by the U.S. Department of Health and Human Services (HHS) inspector general show that foreign governments and corporations could profit from...
News
From the Blood Journals
Pretransplant Bridging With Blinatumomab Reduces MRD in Children With B-Cell Acute...
In a study of children with B-cell acute lymphocytic leukemia (B-ALL) who are about to undergo allogeneic hematopoietic cell transplantation (alloHCT), bridging with blinatumomab...
Pegylated Interferon Leads to High Response Rates in Essential Thrombocythemia and...
According to results of a phase II study published in Blood, treatment with pegylated-interferon-α (PEG-rIFN-α) was associated with an overall response rate (ORR) of...
Multimedia
Pulling Back the Curtain: Robert A. Kyle, MD
In more from our interview with Robert A. Kyle, MD, he discusses his early decision to specialize in hematology and looks back on 70 years...
Pulling Back the Curtain: Saad Z. Usmani, MD
In more from our interview with Saad Z. Usmani, MD, he shares life lessons learned throughout his career.
Pulling Back the Curtain: Anna Schuh, MD, PhD
In more from our interview with Anna Schuh, MD, PhD, she shares her experiences volunteering with hematology patients in Tanzania.
Robert Kreitman: Delayed Versus Concurrent Rituximab in Hairy Cell Leukemia
Robert Kreitman, MD, shares results from a new study suggesting patients with hairy cell leukemia should receive rituximab concurrently with frontline cladribine.
On Location
Examining Pregnancy Outcomes in Eculizumab-Treated Women With Atypical Hemolytic Uremic Syndrome
Women with atypical hemolytic uremic syndrome (aHUS) treated with eculizumab have similar pregnancy outcomes to...
Patients With Hemophilia B Report Poor Bleeding Control With Extended Half-Life Factor IX Products
Extended half-life factor IX (FIX) products have been designed to prolong the time between clotting...
Two Studies Support Using Concizumab as Prophylaxis in Patients With Hemophilia
Concizumab could be a safe and effective subcutaneous prophylactic treatment option for patients with hemophilia...
Hemophilia B: The Next Target for Gene Therapy?
Treatment with a single dose of AMT-061, an investigational gene therapy, led to increased factor...
From ASH Meeting on Hematologic Malignancies: How would you treat relapsed/refractory myeloma after transplant?
During their presentations, MHM speakers will be asking the audience how they would respond to...
From ASH Meeting on Hematologic Malignancies: What are the approved options for relapsed marginal zone lymphoma?
During their presentations, MHM speakers will be asking the audience how they would respond to...
Latest Headlines
ASH Directions
ASH Clinical News Now Available on the ASH Publications App, ABIM Changing Maintenance of...
ASH Clinical News Now Available on the ASH Publications App
The American Society of Hematology (ASH) Publications app provides access to content from Blood, Blood...
ASH Sickle Cell Initiative Wins Top ASAE Prize, ASH-a-Palooza 2019 Announced, and more
ASH Sickle Cell Disease Initiative Wins Top ASAE Prize
The American Society of Hematology (ASH) is proud to have been named a 2019 Power of...
Remembering Stanley Schrier, John Hansen, and more
Remembering Stanley Schrier (1929 – 2019)
Stanley Schrier, MD, a former American Society of Hematology (ASH) president who spent nearly 60 years at Stanford University’s...
Remembering Eugene Frenkel, AMA Announces Reimagining Residency Initiative Award Recipients, and more
Remembering Eugene P. Frenkel (1929 – 2019)
Eugene P. Frenkel, MD, a National Cancer Institute investigator known for his research linking vitamin B12 metabolism and...
Remembering Gustave Eisemann, Cigall Kadoch Wins 2019 Wachtel Cancer Research Prize, and more
Remembering Gustave Eisemann (1926 – 2019)
Gustave Eisemann, MD, passed away on May 26, 2019.
Born in Halberstadt, Germany, Dr. Eisemann came to the U.S. in...
Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia
In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events...
What Does the Future Hold for Gene Therapy in Nonmalignant Hematology?
The human genome contains about 25,000 genes that encode myriad proteins that drive the processes necessary for life. But disruptions, deletions, and mutations can...
The Other Opioid Epidemic
Federal crackdowns on opioid prescribing have shifted the crisis from overdoses to undertreatment
The United States is in the grip of an opioid epidemic that...
